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Abstract Public health courses are emerging as popular
undergraduate offerings, especially at universities with
schools of public health. It is important to note that evolu-
tion has shaped the burden of disease in the modern world in
which we practice and educate for public health. Human
cultures and technologies have modified life on Planet Earth
and have co-evolved with myriad other species, including
microorganisms, plant and animal sources of food, inverte-
brate vectors of disease, and intermediate bird, mammal,
and primate hosts. Molecular mechanisms of evolution have
produced differential resistance or susceptibility to infec-
tious agents, including malaria, plague, smallpox, TB, mea-
sles, and diarrheal and respiratory diseases. The
domestication of sheep and cattle led to natural selection
in favor of human populations able to digest milk through-
out life through persistence into adulthood of lactase
enzyme expression in the intestine, a major story of anthro-
pology. The emergence of a “Western diet” of dairy, refined
cereal grains, refined sugars, vegetable oils, alcoholic
beverages, salt, and omega-6-rich meats has dramatically
altered glycemic load, fatty acid composition, macronutrients,
acid–base balance, sodium/potassium ratio, and fiber content.
This is a major story of nutrition and disease. The results
include epidemics of atherosclerotic cardiovascular disease,
obesity, diabetes, high blood pressure, osteoporosis, certain
cancers, and bowel, inflammatory, and autoimmune disorders.
Another interesting phenomenon is the selection of ex-
cessive hemostatic activity from platelets and the plasma
clotting proteins; what was protective against death from
bleeding after injuries among hunter–gatherers or from
pregnancy-related hemorrhage now contributes to throm-
bosis underlying heart attacks and strokes. Conversely,
there is little pressure against hemostasis and thrombosis
since deaths from these causes occur mostly after the
reproductive years of life. Learning about evolution over mil-
lennia for humans and over hours or days for microbes enliv-
ens the experience of understanding evolutionary biology in
public health context.
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Introduction
Public health education is evolving rapidly in the United
States and around the world. It is ironic that medicine and
healthcare services dominate thinking and expenditures for
health in the United States, since a broader concept of the
social, economic, biological, and technological determinants
of health and disease would treat health care as a variable
within public health. When I became dean of the School of
Public Health & Community Medicine at the University of
Washington in 1982, there were 22 accredited schools of
public health offering the Master of Public Health and
related master’s and doctoral degree programs and conduct-
ing research within the public health sciences. Now there are
48 schools, plus 76 institutions with accredited master’s of
public health programs in the United States. With greatly
enhanced public and student interest in global health, many
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universities are introducing or expanding undergraduate
courses in public health, including environmental health,
nutrition and health, epidemiological surveillance of emerg-
ing infections, health policy, and behavioral and socioeco-
nomic determinants of health. Internet communication is
helping to democratize access to actionable knowledge in
public health, including the SuperCourse of Global Health,
launched by Ronald Laporte and colleagues at the Univer-
sity of Pittsburgh (www.pitt.edu/~super1), a network of an
estimated 65,000 scientists in 174 countries sharing at no
charge 5000 lectures in 31 languages; we have now created
an expanded SuperCourse of Science, housed at the Bibliothe-
ca Alexandrina in Egypt (Laporte et al. 2006).
Evolution and its elements of natural selection, popula-
tion migration, genetic drift, and founder effects have
shaped the human species and continue to do so (Vogel
and Motulsky 1997; Stearns and Koella 2007; Trevathan et
al. 2008; Gluckman et al. 2009; Omenn 2010). Meanwhile,
evolving human cultures and their technologies have mod-
ified and co-evolved with other species. Some changes
occur over numerous generations, even thousands of years,
while others, especially involving microbes, including those
in our own microbiome, are observable in hours or days.
Determinants of adult phenotypes reflect the concept of
“evo-devo,” the interaction of evolutionary and develop-
mental processes (Stearns and Koella 2007). These process-
es are active early in development and influence phenotypes
throughout the lifespan, maintaining or enhancing fitness on
a timescale intermediate between selection and homeostasis.
These manifestations of plasticity are acquired; some are
reversible, others irreversible. These observations are
matched at the molecular level by epigenetic modifications
such as methylation of cytosines in the DNA and methyla-
tion, acetylation, and other modifications of histone proteins
wrapped around the DNA in chromosomes. Plasticity and
epigenetics link genes, development, and environment in the
triangle of the determinants of phenotypes (Fig. 1).
Exposures to chemical, physical, pharmaceutical, dietary,
and microbial agents from environmental sources can affect
in utero and postnatal development.
Drivers of evolution in the context of population health
notably include:
& Infectious agents, including roles of intermediate hosts
in nature, agriculture, and pets
& Dramatic changes in diet and physical activity
& Climate change and other diverse causes of migration of
populations
Advances in population genetics and evolutionary biolo-
gy have facilitated in-depth analyses of gene–environment
interactions in human populations and other species. Public
health research and public health practice focus on under-
standing, protecting, and enhancing the health of communi-
ties and populations. The substrates for the study of
evolution in public health include international patterns of
incidence and prevalence of disease, influences of human
and animal behavior, and cultural changes in agriculture and
food processing (Omenn 2010).
Susceptibility and Resistance to Infectious Diseases
There is ample evidence of the evolution of differential
susceptibility tomajor infectious diseases (Vogel andMotulsky
1997; Ewald 2004). The best-known examples are two differ-
ent types of malaria, due to Plasmodium falciparum and to
Plasmodium vivax.
Malaria The protozoan parasite P. falciparum causes the
most severe form of malaria, with more than one million
deaths annually worldwide. Rates of malaria infection are
correlated with the distribution of the obligate intermediate
host, Anopheles mosquitoes that multiply in stagnant water,
a situation driven by agricultural practices involving defor-
estation both historically and currently. The most obvious
ways to avoid malaria infection are migration away from
geographic areas with high prevalence of Anopheles and
Plasmodium and elimination of the host with antimalarial
chemicals such a dichlorodiphenyl–trichloroethane (DOT),
which was very effective globally before its ban because of
adverse effects on bird populations. Malaria also is an out-
standing example of ecogenetics, the interaction of environ-
mental exposures with inherited susceptibility. Children and
adults with hemoglobin S (sickle cell trait) have red blood cells
less hospitable to the life stage of the malaria parasite that
infects and propagates in the blood, compared with the red
blood cells of individuals with normal HbA. HbS individuals
are more likely to survive the infection and go on to reproduce,
transmitting their genes to the next generations. This is natural




Fig. 1 Roles of plasticity and epigenetics in linking genes, develop-
ment, and environment to produce phenotypes
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the selective factor maintaining the HbS gene in populations in
the face of high mortality from sickle cell anemia when indi-
viduals received a double dose of the gene (HbSS). HbC, HbE,
beta thalassemias, and glucose-6-phosphate dehydrogenase
deficiencies fit this same pattern of “balanced polymorphisms”
(Motulsky 1964). A 20% increase in fitness for individuals
with the trait could balance an 85% decrease in fitness of
homozygous HbSS individuals (Gelehrter et al. 1998).
Phylogenetic analyses have radically revised our thinking
about the origin of P. falciparum. For many years, the evi-
dence seemed to point to co-speciation of P. falciparum in
humans and Plasmodium reichenowi in chimpanzees, evolved
separately from a presumed common ancestor over 5–7 Ma.
That was based on a single isolate of P. reichenowi. Rich et al.
(2009), with eight new isolates, showed that the global totality
of P. falciparum strains is included within the much more
diverse P. reichenowi variation. All extant P. falciparum pop-
ulations seem to have originated from the parasite infecting
chimpanzees by a single-host transfer about 10,000 years ago.
Moreover, inactivation of the gene CMAH in the human
lineage blocked conversion of the sialic acid N-acetylneura-
minic acid (5Ac) to N-glycolylneuraminic acid (Neu5Gc),
making humans resistant to P. reichenowi.
Vivax malaria represents an entirely different mechanism
for evolution of resistance and susceptibility. International
studies of blood group antigens on red blood cells revealed
that West African populations had a Duffy-negative pheno-
type and Fy-/Fy- genotype, which are rare among Caucasian
and Asian populations. Fy-/Fy- individuals are completely
resistant to P. vivax infection because the Fy blood group
antigen is the receptor through which the P. vivax parasite
enters erythrocytes. Whether this infection is sufficiently
life-threatening to fully account for the ubiquitous presence
of Fy- in these populations is not resolved (Vogel and
Motulsky 1997; Omenn 2010).
HIV/AIDS The Duffy mechanism was a clue to explain the
epidemiological observation that some men very highly
exposed to the HIV/AIDS virus did not become infected.
The most striking specific mechanism involves a mutant
CCR5 receptor on lymphocytes (a 32 amino acid deletion).
CCR5 is an essential component of the entry mechanism for
HIV; if there is no entry, there is no infection and there is no
risk of transmission to others. We have no clue as to the
natural selection driver for CCR5 mutations to accumulate
in the human population (Heeney et al. 2006). We now
know 20 polymorphisms of receptors, co-receptors, cyto-
kine ligands, and HLA genes that influence susceptibility to
HIV infection, replication, or relevant innate or adaptive
immunity (Heeney et al. 2006). Viruses have a long history
of co-evolution with molecules of the immune system. The
presence of the CCR5 receptor seems to protect against
West Nile virus; thus, we should be alert that development
and public health use of inhibitors of CCR5 to reduce risk of
HIV/AIDS could lead to increased risk of West Nile virus-
induced encephalitis. Since the emergence of HIV/AIDS in
the early 1980s, public interest in the origins of the HIV
viruses has been intense; there is now strong evidence that
HIV-1 and HIV-2 evolved from chimpanzees and from
sooty mangabeys, respectively. Also, the human genome
has a large array of endogenous retroviral sequences, sug-
gesting a long history of co-evolution with retroviruses.
SARS and Influenza The coronavirus epidemic Severe
Acute Respiratory Syndrome (SARS) appeared in southeast
China and Hong Kong in 2002 and suddenly spread to
Toronto via an air traveler. Modern molecular genetic epi-
demiologic methods swiftly identified the virus and permit-
ted surveillance and control of this epidemic. The key link
was humans handling infected animals. Global surveillance
of highly exposed animal handlers is a strategy to identify
such “emerging infections” at an early stage (Wolfe et al.
1998).
The best known viral infection linked through animal
hosts is influenza. Influenza viruses are highly mutable
and capable of rapid adaptation to selective factors in their
environment, including vaccines. The H5N1 (“avian”) and
H1N1 (“swine”) have quite different origins, with reassort-
ment of strains in their animal hosts. One major barrier
limiting cross-species transmission into humans (and vice
versa) is the evolution of differences in sialic acid linkage
binding specificity between humans and birds and humans
and primates (Rich et al. 2009). Current research uses
reconstituted influenza strains and reverse genetics to seek
the specific genes and gene combinations that may drive
virulence and host range; other researchers model the effects
of vaccines and drugs on evolution and dynamics of the flu
strains.
Microbiome Modern genomic analyses of bacteria DNA
from organisms that are not readily cultured and grown in
the laboratory have revealed remarkable co-existence of
microbes in every ecosystem, including all the internal and
external surfaces of our bodies. These complex microbial
communities are called the “microbiome”. There are an
estimated ten times as many microbial cells as human cells
in our bodies. They perform critical functions in digestion
and host defenses. We provide unique habitats that have
restricted colonization to a relatively small range of micro-
organisms. Our changing hygiene practices, diet, medical
therapies, chemical exposures, and public health programs
continue to cause changes in the microbiome (Turnbaugh et
al. 2007).
Antibiotic Resistance/Evolution in Action Within the micro-
bial world, there is interspecies competition and cooperation
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mediated through exchange of genetic material. Microbes
compete for food and space, adapting to selective pressures.
Fungi are particularly notable for evolution of antimicrobial
chemical products that protect them against bacteria.
Patients have benefitted from these antibiotics found in
nature, starting with Fleming’s use of an extract of Penicil-
lium to kill Gram-positive bacteria. Microbes respond
promptly to negative natural selection in the form of anti-
biotics by developing genetically transmitted resistance to
the action of individual antibiotics or sets of antibiotics.
Strains of Mycobacterium tuberculosis resistant to multiple
drugs put healthcare workers at great risk; when these
strains were recognized about 20 years ago, an aggressive
public health campaign to identify and isolate such patients
and ensure full dosage therapy with whatever agents still
were effective contained the outbreaks. A similar challenge
exists today with multiply resistant Staphylococcal aureus,
acquired mostly in hospitals but increasingly in the commu-
nity. Individuals immune-suppressed due to HIV infection,
steroid treatments, cancer chemotherapy, or genetic immune
deficiency disorders are particularly vulnerable to a broad
range of infectious agents.
Vaccination has been a spectacularly effective public
health intervention over the past 230 years. Modern vacci-
nation approaches can be designed, in at least some situa-
tions, to select for less rather than more virulent strains or
for other desired characteristics. For example, the diphtheria
toxoid vaccine selects against toxin production, which is
what causes disease, rather than against growth or survival
of the Corynebacterium. Vaccination with the seven-
conjugate vaccine against Streptococcus pneumonia has
reduced carriage of penicillin-resistant serotypes but not
invasive isolates (Karnezis et al. 2009). Bioinformatics
tools, databases, and ontologies are helping researchers to
organize information about immunization and to design new
vaccination strategies (www.violinet.org/vaccineontology).
Cultural Evolution—from Hunting and Gathering
to Modern Agriculture and Dietary Practices
Nutrition and diets are particularly salient subjects for mod-
ern public health courses, especially courses for nonmajors.
Important aspects of anthropology, epidemiology, biochem-
istry, genetics, and toxicology need to be covered in an
interdisciplinary fashion.
Origins, Evolution, and Consequences of the Western Diet
Many of the diseases endemic in contemporary Western
populations, and spreading across the globe, have arisen
through discordance between our ancient genetically-
influenced biology and the dietary, cultural, and physical
activity patterns of modern societies. Catchy titles like
“Stone agers in the fast lane” (Eaton et al. 1988) set the
stage. Food-processing procedures and different crops that
were introduced during the Neolithic Period have altered
fundamentally seven critical nutritional characteristics of
ancient hominin diets: glycemic load, fatty acid composi-
tion, macronutrient composition, micronutrient density,
acid–base balance, sodium/potassium ratio, and fiber con-
tent (Cordain et al. 2005). Modern diets are dominated by
dairy products, refined cereal grains lacking germ and
bran, refined sugars (sucrose and fructose), vegetable oils
with low ω-3 and high ω-6 fatty acids, alcoholic bever-
ages, salt, and ω-6 saturated, fatty acid-rich mammalian
meats. These foods displaced the wild plant and animal
foods of our predecessors. Cordain et al. call our diet “the
evolutionary collision of our ancient genome with the
nutritional qualities of recently introduced foods”. This
collision is manifested by many chronic diseases that
dominate public health concerns: obesity, diabetes,
cardiovascular disorders, high blood pressure, dyslipide-
mias, osteoporosis, several cancers, and bowel, inflamma-
tory, and autoimmune diseases. All remain rare among
contemporary hunter–gatherer societies. Modern foods
are also net acid generators, compared with net base-
producing pre-agricultural diets; the latter tended to pro-
tect against osteoporosis, muscle wasting, calcium kidney
stones, high blood pressure, and exercise-induced asthma
(Frassetto et al. 2001).
The Emergence of Dairy-Based Societies and Lactose Tol-
erance Besides the changes above, about 7,000–10,000 years
ago progressive domestication of sheep, goats, and then cattle
occurred in many places; about 6,000 years ago ingestion of
the milk from these animals became a part of the human diet
(Vogel and Motulsky 1997). Milk contains casein protein,
calcium salts, water, and lactose (galactose–glucose disaccha-
ride sugar). The ability to digest lactose declines rapidly in
most humans after weaning because of a normal decline in the
activity of the intestinal enzyme lactase. Before the drinking
of non-human milk, there was no further need for this enzyme
after weaning ended the dependence on mother’s milk. Pop-
ulations with a long history of cattle domestication and milk
drinking selected for the “persistence of lactase” trait. It is an
interesting question which phenotype is “normal”, intolerance
or tolerance for lactose sugar after weaning. The prevalence of
persistence of lactase (lactose tolerance) has reached >90%
among northern Europeans (Swedes), ∼50% in Spanish and
Arab populations, 5–20% among African populations, and
only 1% among Chinese and Native Americans. This genetic
variation is a source of health disparities in public health
nutrition programs.
There are many interesting evolutionary questions about
lactase persistence. How many times has a mutation
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occurred that was then selected positively to reach high
prevalence today—once, twice, many times? How did the
mutation or mutations spread globally? What is the mecha-
nism for what seems to be a regulatory on/off mutation?
Why are symptoms of lactose intolerance so variable within
human populations? See Tishkoff et al. (2007), Hollox and
Swallow (2002), and Itan et al. (2009).
We must always consider that a trait of interest may be
adaptive for more than one reason and may therefore be
selected for some other or additional benefit to reproduction
and survival. In addition to protein, calcium, and sugar, milk
provides water, which is especially important in arid
regions, whereas lactose intolerance leads to water loss via
diarrhea.
The social and public policy context of “nutrigenomics”
can be illustrated with lactose intolerance. The dairy indus-
try has had a long-running successful campaign with “Got
Milk?” advertisements. Originally, the tag line was “Every-
body needs milk.” The Najavo Indian Nation painted their
adobes with federal surplus powdered milk; the unkind
comments of outsiders reflected ignorance of the unpleasant
gastrointestinal symptoms the milk caused in these people,
of whom >95% were lactose intolerant.
In response to objections on behalf of nonwhite U.S.
populations, the tagline was changed to “Milk has some-
thing for everybody.” This case stimulates us to realize that
“the normal state” depends on time and place and environ-
mental conditions. Factors other than the primary gene
variant contribute to variation in severity of symptoms,
making population testing to identify susceptible individuals
before they are symptomatic much more complex than one
might think. Many cases of irritable bowel syndrome might
be attributable to this condition. (For other aspects of
evolution, diet, and public health; see Omenn 2010).
Excessive Hemostasis and Thrombosis
Ischemic atherosclerotic heart disease, leading to myocardi-
al infarction (heart attack), strokes, or heart failure, is a
relatively recent phenomenon for humans. The pathology
of myocardial infarction was described first by Herrick in
1912 (Herrick 1983). The first textbook on heart attacks was
published by Paul Dudley White (1931). A key element of
normal cardiovascular function is hemostasis. For animals
in the wild and for hunter–gatherers, the risk of bleeding to
death after an injury is a strong evolutionary pressure.
Likewise, women experienced pressure to have greater he-
mostasis to survive pregnancy-related hemorrhages. Those
individuals with more active hemostasis were more likely to
survive to sexual maturity and pass on their genes (Coller
1997; Ding and Kullo 2009). At the same time, there was
little selective pressure against excessive hemostasis and
thrombotic disorders, since heart attacks and strokes occur
typically after the active reproductive years.
Understanding these physiological and evolutionary dy-
namics, it was feasible to develop a strategy for a new
pharmaceutical agent and its molecular target. Successful
therapies have been directed at platelet glycoproteins (Coller
1997). These molecules are biosensors and mediators of
integrin receptor modulation, cell/cell adhesion, and throm-
bus formation. Platelets are deposited on damaged athero-
sclerotic plaques together with deposition of fibrin and
thrombin and binding of a large protein called von Wille-
brand factor (vWf), collagen, and tissue factor, culminating
in occlusive thrombus formation. The platelet GPIIb/IIIa
receptors on the luminal surface of the adherent platelets
are activated and undergo a conformation change that
enhances their binding of plasma fibrinogen, vWf, and other
glycoproteins.
The first anti-integrin receptor drug, an antagonist of the
platelet glycoprotein GPIIb/IIIa, was a mouse/human chi-
meric monoclonal antibody (c7E3 Fab; abciximab; ReoPro)
approved by the Food and Drug Administration in the U.S.
in 1994. It was safe and effective in reducing the risk of
ischemic complications of atherosclerotic coronary and ce-
rebrovascular disease (heart attacks, sudden death, and
strokes). Coller (1997) emphasized that this drug is a lead-
ing example of rational drug design—identifying adhesion
molecules as therapeutic targets and then producing succes-
sive generations of effective inhibitors that meet the strin-
gent safety standards for drug approval. The evolutionary
pressure for life-saving hemostasis led to notable redundan-
cy in our hemostatic systems; thus, treatments of patients
with anticoagulants, antiplatelet agents, or thrombolytic
agents have excellent safety profiles. Moreover, this glyco-
protein is expressed only in megakaryotypes (platelet pre-
cursors) and platelets, so it is truly a specific target.
Reflecting the need for instantaneous response to hemor-
rhage, the density of GPIIb/IIIa receptors on platelet surfa-
ces is about 80,000 copies per platelet less than 200 A apart,
with an additional internal pool of receptors in alpha gran-
ules. These receptors are activated by molecular signals of
vessel damage, followed later by a complex process of
inactivation. A vast pharmacologic and clinical literature
supports our understanding of this highly evolved, complex
system of cell adhesion, responses to hemorrhage, and
thrombotic and antithrombotic effects.
Ding and Kullo (2009) provide a broad review of appar-
ent positive, balancing, and purifying (negative) selection in
relation to the many risk factors for coronary heart disease.
Besides hypercoagulability, blood pressure regulation, in-
flammation, lipoprotein and glucose metabolism, metabolic
syndrome, and oxidative stress are examined in light of
climatic and dietary changes and host response to
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pathogens. The recognition of limited variation within hap-
lotypes to identify recent positive selective pressure is illus-
trated with SNP 44 of Calpain-10, involved in regulation of
blood glucose levels (Vander Molen et al. 2005). The sodi-
um hypothesis, that sodium-conserving mechanisms con-
ferred a survival advantage among human populations in
the hot, humid climate of Africa, but then predisposed to
high blood pressure in temperate climates, is well-
supported. The newly-discovered regulator of the low-
density lipoprotein receptor, PCSK9, has multiple interest-
ing evolutionary features; it is also a prime target for new
drug development. Many other associations with coronary
heart disease (e.g., factor V Leiden) lack explanations tied to
natural selection or are quite speculative.
Global Climate Change
The global environment is a popular topic for undergradu-
ates and graduate students from many majors and disci-
plines. Global average surface temperatures have increased
0.8°C (1.4°F) over the past century, mostly in the past
30 years, with a driver to further increases from carbon
dioxide already accumulated in the atmosphere. We can
expect an increasing focus on modeling and predicting
coevolution of humans and many relevant plant, microbial,
invertebrate, and vertebrate species under the selective
forces of global climate change and our attempts to mitigate
and adapt to climate change. Geographic shifts with tem-
perature and humidity will have major effects on agriculture,
vector-borne diseases, and migrations of populations (Last
1993; Ebi and Semenza 2008). The Arctic is particularly
susceptible to climate change, with warming occurring at a
rate twice that of moderate zones, leading to striking
changes in the forests and viability of crops, appearance of
unfamiliar insects and microbes, and thinning and breakup
of the arctic ice. We can anticipate progressive major
changes in temperature, humidity, habitats, vectors, and
transmission for a host of infectious agents. Seasonality is
another important climate variable for infectious diseases,
recognized since the time of Hippocrates. Seasonality pro-
duces alternating periods of high transmission and popula-
tion bottlenecks that limit strain diversity and cause rapid
genetic shifts. Models show that small seasonal changes in
host–pathogen dynamics, including host social behavior and
contact rates, may be sufficient to create large seasonal
surges in disease incidence, which are likely to become
more extreme with climate change.
The term adaptation in the climate change literature is
analogous to the term prevention in public health, ranging
from reduction of greenhouse gas emissions to redesign of
cities to minimize heat islands and heat waves, to surveil-
lance for diseases like tickborne Lyme disease and animal-
to-human transmission of exotic new infections, or to miti-
gation of health disparities in human impacts of rising sea
and river levels. Public health professionals will be critical
to adaptation strategies, hopefully informed by an evolu-
tionary perspective about the interrelations between living
things and their environments.
Closing Comment
Important examples of practical applications of evolutionary
understanding in modern public health include obesity, in-
fluenza, and appropriate uses of antibiotics. As documented
by First Lady Michelle Obama, the Surgeon General, and
the Centers for Disease Control, the prevalence of obesity
and overweight has increased sharply in the past 30 years,
with huge consequences for the burden of chronic diseases
and health care costs. The global epidemic of obesity rep-
resents a combination of rapidly changing, culture-based
behavior changes and discordant genomic predispositions
that cannot be ignored. Meanwhile, we face simultaneous
influenza epidemics from seasonal H1N1 strains and from
lingering or reappearing H5N1 avian flu strains. Finally, we
remain in an arms race with bacteria whose environments
inside us and around us we are constantly changing, stimu-
lating their own rapid evolution.
Evolution, natural selection, and population dynamics act
over very long periods of time. We have learned in recent
years, as highlighted by Science magazine’s “Breakthrough
of the Year 2005,” that we can actually observe “evolution
in action”—in the Galapagos, the Arctic and Antarctic,
hospitals, rural and urban waste streams, and many other
settings, with impacts on public health and implications for
our public health research agenda. We can be confident that
evolutionary perspectives will provide a useful foundation
for research and communication in public health (Nesse and
Stearns 2008; Omenn 2010) as well as in medical care
(Williams and Nesse 1991; AAMC-HHMI 2009; Nesse et
al. 2010; Nesse 2011).
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